S-pantoprazole 10mg Phase III Clinical Study

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Completed	`NCT02575287` - Minimal Injuries From Esophagus Detected by Optical Enhancement System™ Associated to Optical Magnification HD Scopes	N/A
Completed	`NCT01119768` - Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients	Phase 4
Withdrawn	`NCT02039869` - Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT02575287 - Minimal Injuries From Esophagus Detected by Optical Enhancement System™ Associated to Optical Magnification HD Scopes

N/A

Completed

NCT01119768 - Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients

Phase 4

Withdrawn

NCT02039869 - Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02274961
Study type	Interventional
Source	Ahn-Gook Pharmaceuticals Co.,Ltd
Contact	JINHYUNG KIM, Senior Researcher
Phone	82-2-3289-4362
Email	jhkim04@ahn-gook.com
Status	Recruiting
Phase	Phase 3
Start date	October 2014

S-pantoprazole 10mg Phase III Clinical Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms